Machine learning identifies a high-risk diabetic cardiomyopathy phenotype linked to future heart failure
Unsupervised clustering of 25 echocardiographic and biomarker variables in 1,199 ARIC participants with diabetes identified three phenogroups; the group with the greatest cardiac remodelling and neurohormonal-stress abnormalities had 12.1% five-year heart-failure incidence, versus 4.6% and 3.1% in the other groups. A deep-neural-network classifier trained to recognize this phenotype identified corresponding high-risk groups in the external CHS cohort (n=802) and UT Southwestern EHR cohort (n=5,071); phenotype classification was associated with incident heart failure in both.
Technology: Unsupervised hierarchical clustering and a deep neural network (DeepNN) classifier, with random forest variable-importance analysis
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Unsupervised clustering of 25 echocardiographic and biomarker variables in 1,199 ARIC participants with diabetes identified three phenogroups; the group with the greatest cardiac remodelling and neurohormonal-stress abnormalities had 12.1% five-year heart-failure incidence, versus 4.6% and 3.1% in the other groups.
- Still unknown: The cohorts were observational; association with future heart failure does not establish that model-guided intervention improves outcomes. The phenotype is an operational study definition, not a universally accepted diagnostic threshold. The authors describe potential preventive use, but it was not tested. The cohorts were external validations rather than prospective deployment trials.
- AI role: The authors used unsupervised hierarchical clustering of echocardiography and cardiac biomarkers to define outcome-associated diabetic-cardiomyopathy phenogroups, then trained and externally validated a DeepNN classifier to recognize the high-risk phenotype. Random forest permutation importance prioritized NT-proBNP, left-ventricular mass, Doppler measurements, left-atrial dimension and LV end-diastolic volume.
Evidence sources: https://onlinelibrary.wiley.com/doi/10.1002/ejhf.3443
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 88 of works of the same type, year and subfield (OpenAlex work metrics, 8 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.